Marker-independent identification of glioma-initiating cells
- PMID: 20173750
- DOI: 10.1038/nmeth.1430
Marker-independent identification of glioma-initiating cells
Retraction in
-
Retraction: Marker-independent identification of glioma-initiating cells.Nat Methods. 2013 Oct;10(10):1035. doi: 10.1038/nmeth1013-1035c. Nat Methods. 2013. PMID: 24161986 No abstract available.
Abstract
Tumor-initiating cells with stem cell properties are believed to sustain the growth of gliomas, but proposed markers such as CD133 cannot be used to identify these cells with sufficient specificity. We report an alternative isolation method purely based on phenotypic qualities of glioma-initiating cells (GICs), avoiding the use of molecular markers. We exploited intrinsic autofluorescence properties and a distinctive morphology to isolate a subpopulation of cells (FL1(+)) from human glioma or glioma cultures. FL1(+) cells are capable of self-renewal in vitro, tumorigenesis in vivo and preferentially express stem cell genes. The FL1(+) phenotype did not correlate with the expression of proposed GIC markers. Our data propose an alternative approach to investigate tumor-initiating potential in gliomas and to advance the development of new therapies and diagnostics.
Similar articles
-
Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.Neuro Oncol. 2012 Jun;14(6):720-35. doi: 10.1093/neuonc/nos084. Epub 2012 May 14. Neuro Oncol. 2012. Retraction in: Neuro Oncol. 2014 Jun;16(6):889. doi: 10.1093/neuonc/nou086. PMID: 22584872 Free PMC article. Retracted.
-
PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.Mol Cell Biochem. 2011 Mar;349(1-2):149-57. doi: 10.1007/s11010-010-0669-1. Epub 2010 Nov 26. Mol Cell Biochem. 2011. PMID: 21110069
-
Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.Neurosurgery. 2008 Feb;62(2):505-14; discussion 514-5. doi: 10.1227/01.neu.0000316019.28421.95. Neurosurgery. 2008. PMID: 18382330
-
How powerful is CD133 as a cancer stem cell marker in brain tumors?Cancer Treat Rev. 2009 Aug;35(5):403-8. doi: 10.1016/j.ctrv.2009.03.002. Epub 2009 Apr 14. Cancer Treat Rev. 2009. PMID: 19369008 Review.
-
Biology of glioma cancer stem cells.Mol Cells. 2009 Jul 31;28(1):7-12. doi: 10.1007/s10059-009-0111-2. Epub 2009 Jul 20. Mol Cells. 2009. PMID: 19655094 Review.
Cited by
-
Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma.Cancers (Basel). 2021 Feb 16;13(4):828. doi: 10.3390/cancers13040828. Cancers (Basel). 2021. PMID: 33669350 Free PMC article.
-
Glioblastoma cancer stem cells: Biomarker and therapeutic advances.Neurochem Int. 2014 May;71:1-7. doi: 10.1016/j.neuint.2014.03.005. Epub 2014 Mar 19. Neurochem Int. 2014. PMID: 24657832 Free PMC article. Review.
-
Glioma stem cell maintenance: the role of the microenvironment.Curr Pharm Des. 2011;17(23):2386-401. doi: 10.2174/138161211797249260. Curr Pharm Des. 2011. PMID: 21827414 Free PMC article. Review.
-
Human sample authentication in biomedical research: comparison of two platforms.Sci Rep. 2021 Jul 7;11(1):13982. doi: 10.1038/s41598-021-92978-3. Sci Rep. 2021. PMID: 34234171 Free PMC article.
-
Strategies for isolating and enriching cancer stem cells: well begun is half done.Stem Cells Dev. 2013 Aug 15;22(16):2221-39. doi: 10.1089/scd.2012.0613. Epub 2013 May 9. Stem Cells Dev. 2013. PMID: 23540661 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials